Catalyst Funds Management Pty LTD Maxcyte, Inc. Transaction History
Catalyst Funds Management Pty LTD
- $409 Billion
- Q4 2024
A detailed history of Catalyst Funds Management Pty LTD transactions in Maxcyte, Inc. stock. As of the latest transaction made, Catalyst Funds Management Pty LTD holds 17,700 shares of MXCT stock, worth $77,703. This represents 0.02% of its overall portfolio holdings.
Number of Shares
17,700Holding current value
$77,703% of portfolio
0.02%Shares
1 transactions
Others Institutions Holding MXCT
# of Institutions
125Shares Held
67.4MCall Options Held
1KPut Options Held
2K-
Cadian Capital Management, LP New York, NY8.19MShares$35.9 Million1.63% of portfolio
-
Black Rock Inc. New York, NY8.14MShares$35.7 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA5.78MShares$25.4 Million0.0% of portfolio
-
Vitruvian Partners LLP5.04MShares$22.1 Million7.62% of portfolio
-
Morgan Stanley New York, NY4.82MShares$21.1 Million0.0% of portfolio
About MAXCYTE, INC.
- Ticker MXCT
- Exchange NASDAQ
- Sector Healthcare
- Industry Medical Devices
- Shares Outstandng 101,724,000
- Market Cap $447M
- Description
- MaxCyte, Inc., a global life sciences company, engages in the discovery, development, and commercialization of next-generation cell therapies. Its products include ExPERT ATx, a static electroporation instrument for small to medium scale transfection; ExPERT STx, a flow electroporation for protein production and drug development, as well as expr...